0
     

Report Added
Report already added
Dynamics in Post-pandemic Global Generic Injectables Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Generic Injectables Industry: Supply and Demand, Markets and Prices 2021-2027

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Generic Injectables market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Generic Injectables market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables

Segmented by End User/Segment
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva Pharmaceutical
Sanofi
Sandoz International
Pfizer
Mylan
Lupin Pharmaceuticals
Hikma Pharmaceuticals
Fresenius
Biocon
Baxter

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Generic Injectables Market Status and Forecast (2016-2027)
1.3.2 Global Generic Injectables Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Generic Injectables Supply by Company
2.1 Global Generic Injectables Sales Volume by Company
2.2 Global Generic Injectables Sales Value by Company
2.3 Global Generic Injectables Price by Company
2.4 Generic Injectables Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Generic Injectables Market Status by Category
3.1 Generic Injectables Category Introduction
3.1.1 Large Molecule Injectables (Biosimilars)
3.1.2 Small Molecule Injectables
3.2 Global Generic Injectables Market by Category
3.2.1 Global Generic Injectables Sales Volume by Category (2016-2021)
3.2.2 Global Generic Injectables Sales Value by Category (2016-2021)
3.2.3 Global Generic Injectables Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Generic Injectables Market Status by End User/Segment
4.1 Generic Injectables Segment by End User/Segment
4.1.1 Oncology
4.1.2 Infectious Diseases
4.1.3 Cardiology
4.1.4 Diabetes
4.1.5 Immunology
4.1.6 Others
4.2 Global Generic Injectables Market by End User/Segment
4.2.1 Global Generic Injectables Sales Volume by End User/Segment (2016-2021)
4.2.2 Global Generic Injectables Sales Value by End User/Segment (2016-2021)
4.2.3 Global Generic Injectables Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Generic Injectables Market Status by Region
5.1 Global Generic Injectables Market by Region
5.1.1 Global Generic Injectables Sales Volume by Region
5.1.2 Global Generic Injectables Sales Value by Region
5.2 North America Generic Injectables Market Status
5.3 Europe Generic Injectables Market Status
5.4 Asia Pacific Generic Injectables Market Status
5.5 Central & South America Generic Injectables Market Status
5.6 Middle East & Africa Generic Injectables Market Status
6 North America Generic Injectables Market Status
6.1 North America Generic Injectables Market by Country
6.1.1 North America Generic Injectables Sales Volume by Country (2016-2021)
6.1.2 North America Generic Injectables Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Generic Injectables Market Status
7.1 Europe Generic Injectables Market by Country
7.1.1 Europe Generic Injectables Sales Volume by Country (2016-2021)
7.1.2 Europe Generic Injectables Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Generic Injectables Market Status
8.1 Asia Pacific Generic Injectables Market by Country
8.1.1 Asia Pacific Generic Injectables Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Generic Injectables Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Generic Injectables Market Status
9.1 Central & South America Generic Injectables Market by Country
9.1.1 Central & South America Generic Injectables Sales Volume by Country (2016-2021)
9.1.2 Central & South America Generic Injectables Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Generic Injectables Market Status
10.1 Middle East & Africa Generic Injectables Market by Country
10.1.1 Middle East & Africa Generic Injectables Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Generic Injectables Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Generic Injectables Manufacturing Cost Analysis
11.5 Generic Injectables Sales Channel and Distributors Analysis
11.5.1 Generic Injectables Sales Channel
11.5.2 Generic Injectables Distributors
11.6 Generic Injectables Downstream Major Buyers
12 Global Generic Injectables Market Forecast by Category and by End User/Segment
12.1 Global Generic Injectables Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Generic Injectables Forecast by Category
12.2.1 Global Generic Injectables Sales Volume Forecast by Category
12.2.2 Global Generic Injectables Sales Value Forecast by Category
12.2.3 Global Generic Injectables Price Forecast by Category
12.3 Global Generic Injectables Forecast by End User/Segment
12.3.1 Global Generic Injectables Sales Volume Forecast by End User/Segment
12.3.2 Global Generic Injectables Sales Value Forecast by End User/Segment
12.3.3 Global Generic Injectables Price Forecast by End User/Segment
13 Global Generic Injectables Market Forecast by Region/Country
13.1 Global Generic Injectables Market Forecast by Region (2022-2027)
13.1.1 Global Generic Injectables Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Generic Injectables Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Teva Pharmaceutical
14.1.1 Company Information
14.1.2 Generic Injectables Product Introduction
14.1.3 Teva Pharmaceutical Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Sanofi
14.2.1 Company Information
14.2.2 Generic Injectables Product Introduction
14.2.3 Sanofi Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Sandoz International
14.3.1 Company Information
14.3.2 Generic Injectables Product Introduction
14.3.3 Sandoz International Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Pfizer
14.4.1 Company Information
14.4.2 Generic Injectables Product Introduction
14.4.3 Pfizer Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Mylan
14.5.1 Company Information
14.5.2 Generic Injectables Product Introduction
14.5.3 Mylan Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Lupin Pharmaceuticals
14.6.1 Company Information
14.6.2 Generic Injectables Product Introduction
14.6.3 Lupin Pharmaceuticals Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Hikma Pharmaceuticals
14.7.1 Company Information
14.7.2 Generic Injectables Product Introduction
14.7.3 Hikma Pharmaceuticals Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Fresenius
14.8.1 Company Information
14.8.2 Generic Injectables Product Introduction
14.8.3 Fresenius Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Biocon
14.9.1 Company Information
14.9.2 Generic Injectables Product Introduction
14.9.3 Biocon Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Baxter
14.10.1 Company Information
14.10.2 Generic Injectables Product Introduction
14.10.3 Baxter Generic Injectables Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
15 Conclusion
16 Methodology

Kindly Fill The Form Below

Report Title: Dynamics in Post-pandemic Global Generic Injectables Industry: Supply and Demand, Markets and Prices 2021-2027


Valid Invalid number
GRD Survey

SELECT A FORMAT

ADD TO CART BUY NOW